Respiratory syndrome related corona virus (SARS-CoV-2) is a new pathogen causing pandemic. People throughout different countries are quarantined with loss of social life and economy. Physicians are generally using drugs for symptomatic treatment including chloroquine etc. Researchers are working to make way out of this pandemic virus keeping in mind the treatment regimens of other pathogens of respiratory tract infection followed by boosting the immunity of the patients. Natural components are in use to get relief from viral infections and as immunity enhancers. Considering mechanism of action and chemical structure of drug component in use, this article aimed at a mini review to postulate that fused heterocyclic moieties with the functional group’s carboxylic acid, amines, hydroxyl etc. may be considered in designing antiviral drugs for SARS-CoV-2.
Select your language of interest to view the total content in your interested language
Der Pharma Chemica received 11575 citations as per Google Scholar report